New Hampshire Code of Administrative Rules
Saf - Department of Safety
Subtitle Saf-C - Commissioner, Department of Safety
Chapter Saf-C 5900 - EMERGENCY MEDICAL SERVICES RULES
Part Saf-C 5918 - POSSESSION PROCEDURES FOR CONTROLLED DRUGS
Section Saf-C 5918.01 - Agreement
Current through Register No. 40, October 3, 2024
(a) The procurement, storage, and security of controlled prescription drugs shall be regulated in accordance with 21 CFR 1300.
(b) The procurement, storage, and security of non-controlled prescription drugs shall be defined by the unit's MRH, in accordance with the NH patient care protocols.
(c) Prior to obtaining possession of controlled drugs, each unit shall enter into a formal written agreement with its designated MRH.
(d) A separate agreement between the unit and the designated local MRH shall be required for each unit and each of its applicable satellite locations based in this state.
(e) The agreement shall identify and describe the policies and procedures that implement the provisions of Saf-C 5918.03 through Saf-C 5918.07 for the procurement, security, and accountability of controlled drugs and be routed as follows:
(f) Any revisions to the existing agreement, except for a change in identity of the UCDC or the MRH pharmacist pursuant to (l) below, shall necessitate a new agreement, which shall be approved by the director and the SAC.
(g) Units shall conduct controlled drug activity pursuant to the provisions of 21 CFR 1304.03, as an extension of the MRH, DEA registration.
(h) The signed, approved agreements shall be available for inspection, upon demand, by any person or agency charged with the responsibility of enforcing RSA 318 or RSA 318-B.
(i) The division shall maintain a current listing of all units with signed agreements and provide copies to the pharmacy board either upon demand or as changes occur.
(j) The agreement shall be typewritten or legibly printed and identify the following:
(k) The identity and quantities of controlled drugs contained in each drug kit and the total number of drug kit(s) for each unit shall be included in the agreement.
(l) Any changes in the identity of the UCDC or MRH pharmacist shall require written notice to all parties in the agreement and the director within 5 days after making the change.
(See Revision Note at chapter heading for Saf-C 5900) #8520, INTERIM, eff 12-16-05, EXPIRED: 6-14-06
New. #9779-A, eff 9-8-10